» Articles » PMID: 35203602

Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease

Overview
Journal Biomedicines
Date 2022 Feb 25
PMID 35203602
Authors
Affiliations
Soon will be listed here.
Abstract

It is now well known that oxidative stress promotes lipid peroxidation, protein oxidation, activation of proteases, fragmentation of DNA and alteration in gene expression for producing myocardial cell damage, whereas its actions for the induction of fibrosis, necrosis and apoptosis are considered to result in the loss of cardiomyocytes in different types of heart disease. The present article is focused on the discussion concerning the generation and implications of oxidative stress from various sources such as defective mitochondrial electron transport and enzymatic reactions mainly due to the activation of NADPH oxidase, nitric oxide synthase and monoamine oxidase in diseased myocardium. Oxidative stress has been reported to promote excessive entry of Ca due to increased permeability of the sarcolemmal membrane as well as depressions of Na-K ATPase and Na-Ca exchange systems, which are considered to increase the intracellular of Ca. In addition, marked changes in the ryanodine receptors and Ca-pump ATPase have been shown to cause Ca-release and depress Ca accumulation in the sarcoplasmic reticulum as a consequence of oxidative stress. Such alterations in sarcolemma and sarcoplasmic reticulum are considered to cause Ca-handling abnormalities, which are associated with mitochondrial Ca-overload and loss of myofibrillar Ca-sensitivity due to oxidative stress. Information regarding the direct effects of different oxyradicals and oxidants on subcellular organelles has also been outlined to show the mechanisms by which oxidative stress may induce Ca-handling abnormalities. These observations support the view that oxidative stress plays an important role in the genesis of subcellular defects and cardiac dysfunction in heart disease.

Citing Articles

Anti-inflammatory and antioxidant effects of baicalein: targeting Nrf2, and NFĸB in neurodegenerative disease.

Kuwar O, Kalia N Inflammopharmacology. 2025; .

PMID: 40014253 DOI: 10.1007/s10787-025-01698-x.


Deciphering Oxidative Stress in Cardiovascular Disease Progression: A Blueprint for Mechanistic Understanding and Therapeutic Innovation.

Zhang Z, Guo J Antioxidants (Basel). 2025; 14(1).

PMID: 39857372 PMC: 11759168. DOI: 10.3390/antiox14010038.


Loss of PKM2 dysregulates inflammatory signaling in the infarcted murine heart.

Lee K, Williams A, Hara A, Khadka V, Hayashi J, Shohet R Physiol Rep. 2025; 13(1):e70193.

PMID: 39761962 PMC: 11705480. DOI: 10.14814/phy2.70193.


Precise Regulations at the Subcellular Level through Intracellular Polymerization, Assembly, and Transformation.

He L, Meng F, Chen R, Qin J, Sun M, Fan Z JACS Au. 2024; 4(11):4162-4186.

PMID: 39610726 PMC: 11600172. DOI: 10.1021/jacsau.4c00849.


The Nrf2-HO-1 system and inflammaging.

ORourke S, Shanley L, Dunne A Front Immunol. 2024; 15:1457010.

PMID: 39380993 PMC: 11458407. DOI: 10.3389/fimmu.2024.1457010.


References
1.
Bianchi P, Pimentel D, Murphy M, Colucci W, Parini A . A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J. 2005; 19(6):641-3. DOI: 10.1096/fj.04-2518fje. View

2.
Joseph L, Barca E, Subramanyam P, Komrowski M, Pajvani U, Colecraft H . Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes. PLoS One. 2016; 11(1):e0145750. PMC: 4710525. DOI: 10.1371/journal.pone.0145750. View

3.
Schiattarella G, Altamirano F, Tong D, French K, Villalobos E, Kim S . Nitrosative stress drives heart failure with preserved ejection fraction. Nature. 2019; 568(7752):351-356. PMC: 6635957. DOI: 10.1038/s41586-019-1100-z. View

4.
Bertero E, Nickel A, Kohlhaas M, Hohl M, Sequeira V, Brune C . Loss of Mitochondrial Ca Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy. Circulation. 2021; 144(21):1694-1713. DOI: 10.1161/CIRCULATIONAHA.121.053755. View

5.
Warnholtz A, Wendt M, August M, Munzel T . Clinical aspects of reactive oxygen and nitrogen species. Biochem Soc Symp. 2005; (71):121-33. DOI: 10.1042/bss0710121. View